tiprankstipranks
Revance Therapeutics (RVNC)
NASDAQ:RVNC

Revance Therapeutics (RVNC) Stock Investors

562 Followers
Based on 739,972 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold RVNC
On average, investors allocate 4.20% of their portfolios to RVNC
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Negative
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 739,972 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding RVNC

1.4%
Last 7
Days
2.5%
Last 30
Days
Percentages indicate the change in the number of portfolios holding RVNC, out of 739,972 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

RVNC Investor Activity

Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Increased
0.10%
$8.08
Increased
3.88%
$3.02
Opened
2.33%
$9.31
Based on the activity of 13,981 investors who made their portfolios public
The table shows changes in RVNC in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

RVNC Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Merck & Company
4.10%
+0.31%
+2.98%
329.77B
Healthcare
Applied Materials
4.82%
+0.09%
+5.83%
196.77B
Technology
ChargePoint Holdings
4.02%
-0.58%
-2.03%
769.80M
Consumer Cyclical
Bristol-Myers Squibb
3.29%
-0.20%
+2.57%
85.97B
Healthcare
DraftKings
5.82%
-0.65%
+0.80%
34.13B
Consumer Cyclical
Baidu
4.94%
+1.28%
+11.99%
33.95B
Communication Services
Citigroup
4.90%
-0.20%
-0.19%
114.47B
Financial
Devon Energy
5.35%
-1.15%
-2.09%
29.61B
Energy
Fortinet
3.45%
-0.67%
-0.19%
46.31B
Technology
Coherus Biosciences
2.56%
-1.29%
-4.24%
208.80M
Healthcare
Based on the activity of 739,972 active portfolios
Open your Smart Portfolio

RVNC Investor Analysis

RVNC investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
9.3%
of RVNC holders
are under 35
Average Segment Performance
Average P/E Ratio20.54
Beta6.48
Dividend Yield6.25%
RVNC investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
60.0%
of RVNC holders
are between 35–55
Average Segment Performance
Average P/E Ratio19.66
Beta11.65
Dividend Yield6.39%
RVNC investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
30.7%
of RVNC holders
are over 55
Average Segment Performance
Average P/E Ratio19.45
Beta4.12
Dividend Yield7.17%
Overview of age group and performance of RVNC stock investors
See who invests in RVNC according to age group and performance.

FAQ

How many retail Investors hold RVNC?
<0.1% of TipRanks' retail investors hold RVNC in their portfolios.
    What is RVNC Investor Sentiment?
    RVNC’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of RVNC in the last 7 days?
      ▼ 1.4% of TipRanks' retail investors changed their holding of RVNC in the last 7 days.
        What percentage of retail investors changed their holding of RVNC in the last 30 days?
        ▼ 2.5% of TipRanks' retail investors changed their holding of RVNC in the last 30 days.
          What is the average age of retail investors who hold RVNC?
          The average age of RVNC Holders is between 35–55.
            What other stocks have RVNC investors also bought?
            RVNC Investors also bought MRK, AMAT, CHPT, BMY, DKNG, BIDU, C, DVN, FTNT, CHRS.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ALGNAlign Tech
              ALKSAlkermes
              CRLCharles River Labs
              DVADaVita
              GERNGeron
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis